Press Coverage

Neurosurgeons identify malign tumors with Cellvizio optical biopsy

11 September 2015

A team of neurosurgeons in Germany has used the Cellvizio optical biopsy system to identify cancerous brain and spinal tumors in real time, suggesting that the technology could be used for immediate diagnosis in future operations to improve surgical outcomes and patient recovery.

Latest News

Mauna Kea Technologies Announces It Has Secured Over €5M in Firm Subscription Commitments as Required for Its Capital Increase 

Mauna Kea Technologies Announces It Has Secured Over €5M in Firm Subscription Commitments as Required for Its Capital Increase 

Mauna Kea Technologies Reports Third Quarter 2025 Revenue Up +16% at Constant Exchange Rates 

Mauna Kea Technologies Reports Third Quarter 2025 Revenue Up +16% at Constant Exchange Rates 

Mauna Kea Technologies Announces the Terms of its Financing Under its Safeguard Plan 

Mauna Kea Technologies Announces the Terms of its Financing Under its Safeguard Plan 

No results found.